Positive association of the HLA DMB1*0101-0101 genotype with rheumatoid arthritis

Rheumatology

Volumn 38, Issue 5, 1999, Pages 448-452

  Perdriger, A ^a,d   Guggenbuhl, P ^a   Chales G ^a   Yaouanq, J ^b   Quelvennec, E ^c   Bonnard, M N ^c   Pawlotsky, Y ^a   Semana, G ^c  

^a Department of Rheumatology   (France)

^b RENNES UNIVERSITY HOSPITAL   (France)

^c University Immunology Laboratory   (France)

^d SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Genetic susceptibility; HLA DM alleles; HLA DRB1 alleles; Rheumatoid arthritis

Indexed keywords

HLA D ANTIGEN; HLA DMA ANTIGEN; HLA DMB ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; EXON; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENOTYPE; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; OLIGONUCLEOTIDE PROBE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS;

ALLELES; ARTHRITIS, RHEUMATOID; DISEASE SUSCEPTIBILITY; DNA PRIMERS; GENE FREQUENCY; GENOTYPE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HISTOCOMPATIBILITY TESTING; HLA-D ANTIGENS; HLA-DR ANTIGENS; HUMANS;

EID: 0032725578     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/38.5.448     Document Type: Article

References (28)

1. Oilier W, Thomson W. Population genetics of rheumatoid arthritis. Rheum Dis Clin North Am 1992;18:741-59.
2. Winchester R, Dwyer E, Rose S. The genetic basis of rheumatoid arthritis. Rheum Dis Clin North Am 1992;18:761-83.
3. Perdriger A, Guggenbuhl P, Chalès G, Le Dantec P, Yaouanq J, Genetet B et al. The role of HLA-DR-DR and HLA-DR-DP interactions in genetic susceptibility to rheumatoid arthritis. Hum Immunol 1996;46:42-8.
4. Perdriger A, Chalès G, Semana G, Guggenbuhl P, Meyer O, Quillivic F et al. Role of HLA DR-DR and DR-DQ associations in the expression of extraarticular manifestations and rheumatoid factors in rheumatoid arthritis. J Rheumatol 1997;24:1272-6.
5. Mellins E, Kempin S, Smith L, Monji T, Pious D. A gene required for class II-restricted antigen presentation maps to the major histocompatibility complex. J Exp Med 1991;174:1607-15.
6. WHO Nomenclature Committee. Nomenclature for factors of the HLA system, 1995. Hum Immunol 1995;43:149-64.
7. Carrington M, Harding A. Sequence analysis of two novel HLA-DMA alleles. Immunogenetics 1994;40:165.
8. Carrington M, Yeager M, Mann D. Characterization of HLA-DMB polymorphism. Immunogenetics 1993;38: 446-9.
9. Radley E, Alderton RP, Kelly A, Trowsdale J, Beck S. Genomic organization of HLA-DMA and HLA-DMB. Comparison of the gene organization of all six class II families in the human major histocompatibility complex. J Biol Chem 1994;269:18834-8.
10. Kropshofer H, Hämmerling GJ, Vogt AB. How HLA-DM edits the MHC class II peptide repertoire: survival of the fittest? Immunol Today 1997;18:77-82.
11. Arnett FC, Edworthy SM, Bloch DA, McShane D, Fries JF, Cooper NS et al. The American Rheumatism Association 1987: revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988;31:315-24.
12. Glanz S. Primer of biostatistics. New York: McGraw Hill Inc., 1992.
13. Svegaard A, Hauge M, Jersild C, Platz P, Ryder LP, Staub Nielsen LS et al. The HLA system: an introductory survey. Monogr Hum Genet 1975;7:1-100.
14. Imanishi T, Akaza T, Kimura A, Tokunaga K, Gojobori T. Estimation of allele and haplotype frequencies for HLA and complement loci. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991, Proceedings of the Eleventh International Histocompatibility Workshop and Conference. Oxford: Oxford University Press, 1992.
15. Djilali-Saiah I, Benini V, Daniel S, Assan R, Bach JF, Caillat-Zucman S. Linkage disequilibrium between HLA class II (DR, DQ, DP) and antigen processing (LMP, TAP, DM) genes of the major histocompatibility complex. Tissue Antigens 1996;48:87-92.
16. Chevrier D, Giral M, Perrichot R, Latinne D, Coville P, Muller JY et al. Idiopathic and secondary membranous nephropathy and polymophism at TAP 1 and HLA-DMA loci. Tissue Antigens 1997;50:164-9.
17. Pinet V, Combe B, Avinens O, Caillat-Zucman S, Sany J, Clot J et al. Polymorphism of the HLA-DMA and DMB genes in rheumatoid arthritis. Arthritis Rheum 1997; 40:854-8.
18. Carrington M, Stephens JC, Klitz W, Begovich AB, Erlich HA, Mann D. Major histocompatibility complex class II haplotypes and linkage disequilibrium values observed in the CEPH families. Hum Immunol 1994;41:234-40.
19. Kim TG, Carrington M, Choi HB, Kim HY, Han H. Three HLA-DMB variants in Korean patients with autoimmune diseases. Hum Immunol 1996;46:58-60.
20. Yen JH, Chen CJ, Tsai WC, Tsai JJ, Chang JG, Liu HW. HLA-DMA and DMB genotyping in patients with rheumatoid arthritis. J Rheumatol 1997;24:442-4.
21. Takeushi F, Nabeta H, Kuwata S, Tanimoto K, Ito K. Association of DMA and DMB with RA in Japanese. Clin Exp Rheumatol 1997;15:189-92.
22. Reveille JD. The genetic contribution to the pathogenesis of rheumatoid arthritis. Curr Opin Rheumatol 1998; 10:187-200.
23. Benazet JF, Reviron D, Mercier P, Roux H, Roudier J. HLA-DRB1 alleles associated with rheumatoid arthritis in southern France. Absence of extraarticular disease despite expression of the shared epitope. J Rheumatol 1995;22:607-10.
24. Combe B, Eliaou JF, Daures JP, Meyer O, Clot J, Sany J. Prognostic factors in rheumatoid arthritis. Comparative study of two subsets of patients according to severity of articular damage. Br J Rheumatol 1995;34:529-34.
25. Denzin LK, Hammond C, Cresswell P. HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules. J Exp Med 1996;184:2153-65.
26. Weber DA, Evavold BD, Jensen PE. Enhanced dissociation of HLA-DR-bound peptides in the presence of HLA-DM. Science 1996;274:618-20.
27. Stebbins CC, Loss GE, Elias CG, Chervonsky A, Sant AJ. The requirement for DM in class II-restricted antigen presentation and SDS-stable dimer formation is allele and species dependent. J Exp Med 1995;181:223-34.
28. Vogt AB, Moldenhauer G, Hämmerling GJ, Kropshofer H. HLA-DM stabilizes empty HLA-DR molecules in a chaperone-like fashion. Immunol Lett 1997;57:209-11.